Indicación
Vipidia is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).
En otros países
Los mismos principios activos en otros registros, empezando por la misma marca.
Fichas nacionales
Los registros nacionales en los que figura este medicamento de la UE.